From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression

R Thapa, O Afzal, M Afzal, G Gupta, AA Bhat… - … -Research and Practice, 2023 - Elsevier
Cancer is a complex disease that causes abnormal genetic changes and unchecked cellular
growth. It also causes a disruption in the normal regulatory processes that leads to the …

[HTML][HTML] Artificial intelligence in urooncology: what we have and what we expect

A Froń, A Semianiuk, U Lazuk, K Ptaszkowski… - Cancers, 2023 - mdpi.com
Simple Summary Our study provides an overview of the current state of artificial intelligence
applications in urooncology and explores potential future advancements in this field. With …

[HTML][HTML] Prostate cancer: genetics, epigenetics and the need for immunological biomarkers

G Rafikova, I Gilyazova, K Enikeeva, V Pavlov… - International Journal of …, 2023 - mdpi.com
Epidemiological data highlight prostate cancer as a significant global health issue, with high
incidence and substantial impact on patients' quality of life. The prevalence of this disease is …

Correlation of the anticancer and pro-oxidant behavior and the structure of flavonoid-oxidovanadium (IV) complexes

LG Naso, EG Ferrer, PAM Williams - Coordination Chemistry Reviews, 2023 - Elsevier
The phytochemical compounds flavonoids have potential medicinal benefits such as
antioxidant, anti-inflammatory, anticancer and antiviral action. These properties can be …

Succinylation of CTBP1 mediated by KAT2A suppresses its inhibitory activity on the transcription of CDH1 to promote the progression of prostate cancer

J Zhou, X Yan, Y Liu, J Yang - Biochemical and biophysical research …, 2023 - Elsevier
CTBP1 has been demonstrated as a co-repressor in the transcriptional regulation of
downstream genes and is involved in various cell process. However, the mechanism of …

N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner

Y Wang, P Jin, X Wang - Apoptosis, 2024 - Springer
Increasing data and literature have illustrated that tumor immune escape represents a major
source of tumor formation and recrudesce. Besides, novel findings also indicate that RNA …

[HTML][HTML] Review of current treatment intensification strategies for prostate cancer patients

S Wasim, J Park, S Nam, J Kim - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer (PCa) affects millions of men worldwide, and the mortality
rate for locally advanced or metastasized cancer cases remains high. Despite the …

[HTML][HTML] The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 …

P Yu, C Zhu, X You, W Gu, X Wang, Y Wang, R Bu… - Cell Death & …, 2024 - nature.com
With the high incidence of urogenital tumors worldwide, urinary system tumors are among
the top 10 most common tumors in men, with prostate cancer ranking first and bladder …

[HTML][HTML] 28S rRNA-Derived Fragments Represent an Independent Molecular Predictor of Short-Term Relapse in Prostate Cancer

MA Diamantopoulos, KK Georgoulia, P Levis… - International Journal of …, 2023 - mdpi.com
Prostate cancer (PCa) is a global health concern, being a leading cause of cancer-related
mortality among males. Early detection and accurate prognosis are crucial for effective …

[HTML][HTML] An In-Depth Look Into the epidemiological and etiological aspects of prostate cancer: a literature review

M Al-Ghazawi, H Salameh, S Amo-Afful, S Khasawneh… - Cureus, 2023 - ncbi.nlm.nih.gov
Prostate cancer is the second most frequently diagnosed cancer among men worldwide,
and it represents a substantial worldwide health issue, primarily impacting men as they grow …